Navy beans take on fatty liver: a diet swap put to the test

NCT ID NCT07730853

First seen Jul 28, 2026 · Last updated Aug 13, 2026 · Updated 5 times

Summary

This trial tests whether replacing some of the usual diet with navy beans — without changing total calories — is a practical and acceptable way to help manage metabolic dysfunction-associated steatotic liver disease (MASLD) in adults with intermediate-stage liver fibrosis. Forty participants will follow either their normal diet or a navy-bean-rich diet for 12 weeks, then switch. The study focuses on whether people can stick with the diet and find it acceptable, not on whether it improves liver health directly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a diet rich in navy beans, replacing an equal number of calories from the usual diet
What this could lead to
If the diet proves feasible and acceptable, it could point toward a simple, affordable dietary strategy to help manage fatty liver disease.
What could go wrong
This is a small early-stage trial focused on feasibility, not on proving the diet improves liver health. Results may not apply to everyone, and some people may find the diet hard to stick with.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mount Sinai Hospital

    New York, New York, 10029, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.